• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Massive layoffs today and tomorrow at Pfizer









It's not massive and didn't effect every division. Only those selling epilepsy drugs. Only 4% in that division are being let go. So as my brother put it, those on pips are gone. Management is where the bulk of layoffs are.